Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Bilinsky Igor exercised options for 8,790 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Bilinsky Igor (Chief Operating Officer) exercised options for 8,790 Iovance Biotherapeutics, Inc. shares, leaving 130,083 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
8,790 shares
Holding after
130,083 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise8,790134,556Direct
Jun 1, 2026Common StockShares withheld for tax4,473US$3.96130,083Direct

Source

View original at SEC

Related